T1	Chemical 32 40	low-dose
T2	Chemical 97 119	antiangiogenic effects
T6	Chemical 272 289	angiogenic agents
T7	Chemical 300 304	bFGF
T8	Chemical 306 310	VEGF
T9	Chemical 315 319	IL-6
T10	Chemical 360 378	thalidomide 100 mg
T15	Chemical 643 647	VEGF
T19	Chemical 883 887	VEGF
T22	Chemical 1002 1006	bFGF
T23	Chemical 1011 1015	VEGF
T25	Chemical 1091 1105	growth factors
T26	Disease 1107 1122	Adverse effects
T28	Disease 1146 1164	morning drowsiness
T32	Disease 1254 1283	peripheral sensory neuropathy
T34	Disease 1388 1408	subclinical evidence
T35	Disease 1412 1433	peripheral neuropathy
T38	Disease 1673 1694	peripheral neuropathy
